内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Dandekar Atul. Officer active across 1 company, notably Maze Therapeutics, Inc.. In total, 20 disclosures have been logged. Split: 0 buy · 11 sells. Total volume traded: €858k. History available since 29 December 2025. The latest transaction was filed on 2 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dandekar Atul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
2,800 股@ US$26.3760.0049% mcap3.4% 占其流量Common StockSEC:0002050167-26-000027:0
391 股@ US$27.12110.0007% mcap0.5% 占其流量Common StockSEC:0002050167-26-000027:1
3,207 股@ US$26.01330.0055% mcap3.8% 占其流量Common StockSEC:0002050167-26-000027:2
36 股@ US$25.810.0001% mcap0.0% 占其流量Common StockSEC:0002050167-26-000027:3
12,500 股0Common StockSEC:0002050167-26-000025:0
7,500 股@ US$10.420.0051% mcap3.8% 占其流量Common StockSEC:0002050167-26-000023:0
7,500 股@ US$27.57650.014% mcap10.1% 占其流量Common StockSEC:0002050167-26-000023:1
7,500 股@ US$10.420.0052% mcap4.5% 占其流量Common StockSEC:0002050167-26-000019:0
7,100 股@ US$27.30640.013% mcap11.3% 占其流量Common StockSEC:0002050167-26-000019:1
400 股@ US$27.890.0007% mcap0.6% 占其流量Common StockSEC:0002050167-26-000019:2
7,500 股Common StockSEC:0002050167-26-000016:0
7,500 股Common StockSEC:0002050167-26-000016:1
7,500 股@ US$10.420.0043% mcap29.1% 占其流量Common StockSEC:0002050167-26-000008:0
7,500 股@ US$25.37320.010% mcap70.9% 占其流量Common StockSEC:0002050167-26-000008:1
7,500 股@ US$10.4213.9% 占其流量Common StockSEC:0002050167-26-000006:0
6,710 股@ US$29.255635.0% 占其流量Common StockSEC:0002050167-26-000006:1
790 股@ US$30.01734.2% 占其流量Common StockSEC:0002050167-26-000006:2
7,500 股@ US$10.425.2% 占其流量Common StockSEC:0002050167-26-000005:0
7,500 股@ US$10.425.2% 占其流量Common StockSEC:0002050167-26-000003:0
72,400 股@ US$10.4250.8% 占其流量Common StockSEC:0002050167-25-000007:0
About Dandekar Atul
Dandekar Atul is a declarant linked to Maze Therapeutics, Inc. (XNAS), where the listed role is CSBO. Across 13 filings in total, the sampled recent filings run from 2025-12-31 to 2026-07-31, with EUR 0 of buys and EUR 534868 of sells, and the most common transaction nature is Levée d'options.